Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology- A Population-based Study.

Related Articles Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology- A Population-based Study. Clin Gastroenterol Hepatol. 2017 Jul 07;: Authors: Bojesen RD, Riis LB, Høgdall E, Nielsen OH, Jess T Abstract BACKGROUND & AIMS: Inflammatory bowel disease (IBD) may increase risk of small bowel cancer (SBC). However, little is known of the characteristics and features of IBD-SBC, due to a low number of cases worldwide. We performed a population-based study of IBD and SBC to calculate risk and increase our understanding of clinical characteristics and histopathological…

Read More

Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.

Related Articles Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2017 Jun 19;: Authors: Eluri S, Parian AM, Limketkai BN, Ha CY, Brant SR, Dudley-Brown S, Efron JE, Fang SG, Gearhart SL, Marohn MR, Meltzer SJ, Bashar S, Truta B, Montgomery EA, Lazarev MG Abstract BACKGROUND: It is unclear whether intensive surveillance protocols have resulted in a decreased incidence of colorectal cancer (CRC) in inflammatory bowel disease (IBD). AIMS: To determine the prevalence and characteristics of IBD associated…

Read More

A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis.

Related Articles A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis. Am J Gastroenterol. 2017 Jun;112(6):833 Authors: Komeda Y, Kashida H, Sakurai T, Kono M, Nagai T, Asakuma Y, Hagiwara S, Matsui S, Watanabe T, Chikugo T, Kudo M PMID: 28572650 [PubMed – in process] PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/28572650?dopt=Abstract

Read More

Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.

Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry. Am J Gastroenterol. 2017 May 23;: Authors: Chaparro M, Ramas M, Benítez JM, López-García A, Juan A, Guardiola J, Mínguez M, Calvet X, Márquez L, Fernández Salazar LI, Bujanda L, García C, Zabana Y, Lorente R, Barrio J, Hinojosa E, Iborra M, Cajal MD, Van Domselaar M, García-Sepulcre MF, Gomollón F, Piqueras M, Alcaín G, García-Sánchez V, Panés J, Domènech E, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP Abstract OBJECTIVES: The objective of this study was (a) To know…

Read More

Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study.

Related Articles Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study. J Crohns Colitis. 2017 May 01;11(5):571-577 Authors: Hovde Ø, Høivik ML, Henriksen M, Solberg IC, Småstuen MC, Moum BA Abstract Background and Aims: Whether patients with inflammatory bowel diseases [IBDs] have increased risk of developing cancer has been debated. The aims of the study were to determine the prevalence of intestinal/extraintestinal cancers in an IBD cohort 20 years after diagnosis and to assess whether these patients had an increased cancer-specific risk…

Read More

Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Related Articles Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017 Apr;2(4):269-276 Authors: Bopanna S, Ananthakrishnan AN, Kedia S, Yajnik V, Ahuja V Abstract BACKGROUND: The increased risk of colorectal cancer in ulcerative colitis is well known. The risk of sporadic colorectal cancer in Asian populations is considered low and risk estimates of colorectal cancer related to ulcerative colitis from Asia vary. This meta-analysis is an Asian perspective on the risk of colorectal cancer related to ulcerative colitis. METHODS: We…

Read More
<< Go Back